A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects

See also
Status	Clinical Trial	Phase
Completed	`NCT01937975` - The Pharmacokinetics of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Participants With Renal Insufficiency (MK-5172-050)	Phase 1
Completed	`NCT03284164` - Evaluation of Effect of Renal Impairment on the PK of Tenofovir Exalidex	Phase 1
Completed	`NCT05992155` - A Study of TAK-279 in Adults With or Without Kidney Problems	Phase 1
Completed	`NCT05004311` - The Effect of Severe Kidney Impairment on Cenerimod Pharmacokinetics	Phase 1
Completed	`NCT04963738` - A Study of JNJ-73763989 in Adult Participants With Renal Impairment	Phase 1
Terminated	`NCT02508740` - Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment	Phase 1
Active, not recruiting	`NCT01529658` - Renal Hypothermia During Partial Nephrectomy	N/A
Terminated	`NCT00984113` - Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment	Phase 1
Completed	`NCT00750620` - A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment	Phase 1
Completed	`NCT00842868` - The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases	N/A
Completed	`NCT00499187` - Fanconi Syndrome Due to ARVs in HIV-Infected Persons	Phase 4
Completed	`NCT01331941` - A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function	Phase 1
Completed	`NCT05489614` - A Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Olpasiran in Participants With Normal Renal Function and Participants With Various Degrees of Renal Impairment	Phase 1
Completed	`NCT03259087` - Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)	Phase 1
Completed	`NCT05086107` - Pharmacokinetics and Safety of BV100 Administered as Single Intravenous Infusion to Subjects With Renal Impairment	Phase 1
Recruiting	`NCT05349851` - Bowel Cleansing With Renal Impairment
Completed	`NCT03660241` - A Renal Impairment Study for PF-04965842	Phase 1
Recruiting	`NCT06037031` - A Study to Learn How the Body Processes the Study Medicine Called PF-07923568 in People With Loss of Kidney Function	Phase 1
Completed	`NCT03289208` - Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment	Phase 1
Completed	`NCT02942810` - To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment	Phase 1

NCT number	NCT05200286
Study type	Interventional
Source	F2G Biotech GmbH
Contact
Status	Completed
Phase	Phase 1
Start date	February 10, 2022
Completion date	December 13, 2022

A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Renal Impairment

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms